Danaher Corporation (NYSE:DHR) is one of the best non-tech stocks to buy according to analysts. Masimo, Danaher Corporation’s ...

Clair, a startup founded by Stanford graduates, is developing a wearable hormone-tracking device to improve how women access and understand their hormonal health. The company, started by Jenny Duan ...

The wearable patch market is estimated at roughly $ 13- $15 billion in 2026 and is expected to reach the low-twenties of ...

Samsung’s health features are growing apace, and will offer insights through wearables and other devices, the company’s ...

On 22 June 2026, Masimo, a Danaher company, received FDA 510(k) clearance for an AI-enabled opioid-induced respiratory ...

OTC glucose monitors are moving into wearable health tech, but the clearest benefits remain for diabetes and prediabetes ...

A large Scottish study suggests that those with hypertension who regularly monitor their readings at home and share the ...

"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.

Ultrahuman Ring Pro starts shipping worldwide today at $479 with lifetime access to all core health features — no ...